BenchSci-AI Software

At BenchSci, our aim is to exponentially increase the speed and quality of life-saving research by empowering scientists with advanced biomedical AI to run more successful experiments. Our vision as an organization is to bring medicine to patients 50% faster by 2025. Backed by F-Prime, Inovia, Golden Ventures, and Google’s AI fund, Gradient Ventures, we provide an indispensable tool for more than 41,000 scientists at 15 top 20 pharmaceutical companies and 4,300 leading academic centers. Currently, there are 200 of us, and we are expanding! For more information, please email us at surbankova@benchsci.com.